Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort is a paper indexed in PICO Portal from OpenAlex.
How many citations does Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort have?
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort has 207 citations in the OpenAlex counts PICO Portal stores.
When was Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort published?
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort has 2019 year in the PICO Portal index.
What is the open-access status of Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort?
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort has green oa status in the PICO Portal index.
What is the DOI of Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort?
The DOI for Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort is on the source record.
What is the PMID of Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort?
The PMID for Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort is on the source record.
What is the OpenAlex record for Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort?
The OpenAlex for Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort is on the source record.